Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Schedule of Reconciliation of Net (Loss) Income Per Basic and Diluted Common Share Outstanding) (Details)

v3.23.2
Net (Loss) Income Per Share (Schedule of Reconciliation of Net (Loss) Income Per Basic and Diluted Common Share Outstanding) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jun. 30, 2023
Jun. 30, 2022
Net income (loss) $ 6,314,204 $ (38,792,906) $ (36,842,179) $ (22,195,576) $ (14,177,830) $ (6,380,006) $ (69,320,881) $ (42,753,412)
Basic weighted average common shares outstanding 88,266,152     80,088,431     83,218,748 80,054,594
Total net effect of dilutive instruments 35,364              
Diluted weighted average common shares outstanding 88,301,516     80,088,431     83,218,748 80,054,594
Net income (loss) per basic common share outstanding $ 0.07     $ (0.28)     $ (0.83) $ (0.53)
Net income (loss) per diluted common share outstanding $ 0.07     $ (0.28)     $ (0.83) $ (0.53)
Stock Options [Member]                
Stock appreciation rights 25,962              
Stock Appreciation Rights (SARs) [Member]                
Stock appreciation rights 9,402